LNC
52
2
PYPL
43
-4
WAT
54
2
AEE
61
3
VRSN
53
-2
ADT
32
9
DTE
63
7
USB
44
-3
CMS
67
3
STI
17
3
PSA
66
3
MTCH
44
-4
O
31
3
FLS
56
-3
DOV
64
-5
BWA
45
-4
EL
30
-3
HP
41
-4
PFE
30
-3
PSX
40
-4
LNC
52
2
PYPL
43
-4
WAT
54
2
AEE
61
3
VRSN
53
-2
ADT
32
9
DTE
63
7
USB
44
-3
CMS
67
3
STI
17
3
PSA
66
3
MTCH
44
-4
O
31
3
FLS
56
-3
DOV
64
-5
BWA
45
-4
EL
30
-3
HP
41
-4
PFE
30
-3
PSX
40
-4
Financhill
Back

Amicus Therapeutics Quote, Financials, Valuation and Earnings

Free 23-page book shares my #1 indicator to use

Here's the 23-page free book.
Buy
53

FOLD
Amicus Therapeutics

Last Price:
11.30
Seasonality Move:
-7.74%

7 Day Trial

ALL ACCESS PASS

$ 7

10 minutes on Tuesday - $1,270 by Friday?

Click here to discover how this "odd" trade could double your money each week.

Amicus Therapeutics Price Quote

$11.30
+0.01 (+2.73%)
(Updated: September 21, 2024 at 6:23 AM ET)

Amicus Therapeutics Key Stats

Buy
53
Amicus Therapeutics (FOLD) is a Buy
Day range:
$10.77 - $11.34
52-week range:
$9.02 - $14.57
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.45
P/B ratio:
25.27%
Volume:
4.1M
Avg. volume:
2.3M
1-year change:
-8.21%
Market cap:
$3.3B
Revenue:
$399.4M
EPS:
$-0.39

How Much Does Amicus Therapeutics Make?

Is Amicus Therapeutics Growing As A Company?

  • What Is Amicus Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.34%
  • What Is Amicus Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Amicus Therapeutics Stock Price Performance

What Is Amicus Therapeutics 52-Week High & Low?

Amicus Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Amicus Therapeutics?

Is Amicus Therapeutics Cash Flow Positive?

  • What Is FOLD Cash Flow From Operations?
    Cash flow from operations (TTM) is -$41.9M
  • What Is Amicus Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $31.7M
  • What Is Amicus Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.6M

Amicus Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    FOLD return on invested capital is -22.81%
  • What Is Amicus Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -15.97%
  • What Is FOLD Return On Equity?
    ROE is a measure of profitability and is -89.45%

Amicus Therapeutics Earnings Date & Stock Price

Amicus Therapeutics Competitors

Amicus Therapeutics Dividend Yield

Amicus Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 283.63%
Revenue: 34.04% 4.47%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 17.25
Upside from Last Price: 52.79%

Major Shareholders

  • How many FOLD shares are owned by institutional investors?
    510.3M FOLD shares are owned by institutional investors
  • How many FOLD shares are owned by insiders?
    5.5M FOLD shares are owned by insiders